PLCB2: A Drug Target / Disease Biomarker (G5330)

Target Name: PLCB2

NCBI ID: G5330

PLCB2

PLCB2: A Drug Target / Disease Biomarker

PLCB2, also known as P2R1, is a protein that is expressed in the brain and is involved in the regulation of pain signaling. It is a G protein-coupled receptor (GPCR), which means it is a transmembrane protein that is connected to intracellular signaling pathways. PLCB2 is a potential drug target or biomarker for various neurological and psychiatric disorders, including chronic pain, anxiety, and depression.

The PLCB2 gene was first identified in 2001 and has been extensively studied since then. It is located on chromosome 7 and has 21 exons. PLCB2 is a small protein that has been shown to play a critical role in pain signaling. It is expressed in the brain and is involved in the regulation of pain signaling pathways.

PLCB2 is a GPCR, which means it is a transmembrane protein that is connected to intracellular signaling pathways. It is made up of a pre-伪, 伪, and 尾 subunit. The pre-伪 subunit is the N-terminus and the 伪 subunit is the middle part of the protein. The 尾 subunit is the C-terminus and is responsible for the binding of ligands.

PLCB2 is involved in several signaling pathways, including the nociceptive pain signaling pathway, the endocannabinoid signaling pathway, and the dopamine signaling pathway. PLCB2 is a critical regulator of pain signaling in the brain and has been shown to play a role in the development and progression of chronic pain conditions.

PLCB2 is also involved in the regulation of anxiety and depression. Studies have shown that PLCB2 is involved in the regulation of anxiety and depression-related behaviors, including anxiety- and depression-like behaviors in animals. PLCB2 has also been shown to play a role in the regulation of neurotransmitter systems, including dopamine, in animals.

PLCB2 is a potential drug target or biomarker for various neurological and psychiatric disorders, including chronic pain, anxiety, and depression. Studies have shown that PLCB2 is involved in the regulation of pain signaling pathways and is a potential target for pain medications. Additionally, PLCB2 has been shown to be involved in the regulation of anxiety and depression-related behaviors and may be a potential target for these disorders.

In conclusion, PLCB2 is a protein that is expressed in the brain and is involved in the regulation of pain signaling. It is a GPCR and has been shown to play a critical role in pain, anxiety, and depression-related behaviors. PLCB2 is a potential drug target or biomarker for these disorders and may be a valuable tool in the development of new treatments for these conditions. Further research is needed to fully understand the role of PLCB2 in pain, anxiety, and depression.

Protein Name: Phospholipase C Beta 2

Functions: The production of the second messenger molecules diacylglycerol (DAG) and inositol 1,4,5-trisphosphate (IP3) is mediated by activated phosphatidylinositol-specific phospholipase C enzymes

The "PLCB2 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about PLCB2 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets